APPLICATION OF RECENTLY PROPOSED EBMT/ ASTCT/ CIBMTR/APCMT CONSENSUS RISK STRATIFICATION FOR TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) IN CHILDREN

被引：0
|
作者：
Schoettler, Michelle [1 ,2 ]
Bryson, Elyse [1 ,2 ]
Spencer, Kathleen [1 ,2 ]
Qayed, Muna [1 ,2 ]
Chonat, Satheesh [1 ,2 ]
Westbrook, Adrianna [1 ,2 ,3 ]
Williams, Kirsten [1 ,2 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[3] Pediat Biostatist Core, Atlanta, GA USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O130
引用
收藏
页码：118 / 119
页数：2
相关论文
共 38 条
  • [31] ECULIZUMAB PK/PD MODELING AND SIMULATION FOR PERSONALIZED DOSE ADJUSTMENT IN BLEEDING PATIENTS WITH STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA).
    Mizuno, K.
    Dandoy, C.
    Teusink-Cross, A.
    Davies, S.
    Vinks, A.
    Jodele, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S37 - S37
  • [32] HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) HAS HIGH-RATE MORTALITY WHEN TREATED WITH CONVENTIONAL APPROACHES
    Iovino, L.
    Mazziotta, F.
    Orciuolo, E.
    Buda, G.
    Morganti, R.
    Caracciolo, F.
    Galimberti, S.
    Petrini, M.
    Benedetti, E.
    HAEMATOLOGICA, 2017, 102 : 168 - 169
  • [33] Steroid-Refractory Graft Versus Host Disease (SR-GVHD) of the Gastrointestinal (GI) Tract is Frequently Associated with Transplant Associated Thrombotic Microangiopathy (TA-TMA)
    Wall, Sarah
    zhao, Qiuhong
    Agyeman, Akwasi
    Devine, Steven M.
    Cataland, Spero
    Vasu, Sumithira
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S193 - S194
  • [34] Transient elevation of plasma C5b-9 is not related to transplant-associated thrombotic microangiopathy (TA-TMA) in children treated with allogeneic hematopoietic stem cell transplantation (alloHSCT)
    Borsa, Nicolo' Ghiringhelli
    Taylor, Amanda
    Jones, Michael
    Zhang, Yuzhou
    Nester, Carla
    Smith, Richard J. H.
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2303 - 2303
  • [35] Severe periostitis and myositis as a manifestation of transplant-associated thrombotic microangiopathy (TA-TMA) after peripheral blood stem cell transplantation from unrelated donor for homozygous β-thalassemia
    da Cunha-Riehm, Claudia Bettoni
    Maecker-Kolhoff, Britta
    Kafa, Kinan
    Lamottke, Britta
    Sauer, Martin
    Sykora, Karl-Walter
    BONE MARROW TRANSPLANTATION, 2018, 53 : 372 - 373
  • [36] Transplant Associated Thrombotic Microangiopathy (TA-TMA) Commonly Occurs after Steroid-Refractory or Dependent Gastrointestinal (GI) Graft Versus Host Disease (GVHD) and Contributes to Post-Transplant Morbidity
    Wall, Sarah A.
    Zhao, Qiuhong
    Ranganathan, Parvathi
    Elder, Patrick
    William, Basem M.
    Puto, Marcin
    Roddy, Julianna
    Klisovic, Rebecca B.
    Blum, William
    Benson, Don M., Jr.
    Jaglowski, Samantha
    Mims, Alice S.
    Brammer, Jonathan E.
    Efebera, Yvonne A.
    Hofmeister, Craig C.
    Andritsos, Leslie
    Penza, Sam
    Walker, Allison R.
    Devine, Steven M.
    Cataland, Spero R.
    Vasu, Sumithira
    BLOOD, 2017, 130
  • [37] TRANSPLANT ASSOCIATED-THROMBOTIC MICROANGIOPATHY (TA-TMA) IN PEDIATRIC NEUROBLASTOMA (NB) PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): A CASE-CONTROL STUDY IDENTIFYING EARLY CLINICAL MARKERS OF DISEASE
    Laskin, B. L.
    Goebel, J.
    Davies, S. M.
    Bleesing, J. J.
    Mehta, P. A.
    Filipovich, A. H.
    Khoury, J. C.
    Paff, Z. N.
    Jodele, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S205 - S205
  • [38] ECULIZUMAB COMPLEMENT-MEDIATED PK/PD MODEL-INFORMED SIMULATIONS REVEAL THE NEED FOR ALTERNATIVE DOSING REGIMENS DURING MAINTENANCE THERAPY FOR STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA).
    Mizuno, K.
    Dandoy, C.
    Teusink-Cross, A.
    Davies, S.
    Vinks, A.
    Jodele, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S32 - S33
1234